Mark joined PCI in 2014 as a member of the Corporate Alliances team. Mark serves as the alliance manager for several key alliance partnerships, taking an active role in ensuring that Penn and its partners meet their respective goals and maximize their collaboration opportunities. He has licensed several innovative cell therapy intellectual property portfolios to start-up companies that have raised substantial equity financing, have initiated multiple first-in-human trials, and have committed large amounts of research and development funding to Penn under alliance program partnership agreements.
Prior to PCI, Mark worked for 12 years in marketing and business roles for companies in the life science research tool sector. Mark received a Ph.D. in Cell and Molecular Biology from Penn and attended Pennsylvania State University as an undergrad.
